Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin added to latency antibiotics for late preterm prelabor rupture of membranes
MOH_2025-04-30_014029Phase 4Not yet recruiting
- Sponsor
- נעה גונן
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin, ampicillin and amoxicillin in rupture of membranes (2 arms), sponsored by נעה גונן. Primary endpoint: Composite neonatal morbidity. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
azithromycinampicillinamoxicillin
03
Conditions
rupture of membranes
Beyond the preview
Go deeper on MOH_2025-04-30_014029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-04-30_014029.